Stay updated with breaking news from World Coronavirus Dispatch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read more about World Coronavirus Dispatch: What socialising may look like after lockdowns on Business Standard. Pandemic fuels gun buying in America, Tens of thousands of Brazilians demand Bolsonaro's impeachment, and other pandemic-related news across the globe
Global infections: 150,536,843 Global deaths: 3,165,999 Nations with most cases: US (32,288,909), India (18,762,976), Brazil (14,590,678), France (5,653,533), Russia (4,788,700). Source: AstraZeneca struggles with data needed for vaccine’s approval AstraZeneca's struggle to get its vaccine rolled out in United States continues as the officials are finding it hard to put together adequate data for its aproval by the drug regulator. The officials were said to have told the regulator that it needs time until mid-May to forward the application, delaying the earlier deadline of mid-April....
Read more about World Coronavirus Dispatch: Germans denying Covid put under surveillance on Business Standard. New York to end curfew on bars and restaurants next month, Japan to allow vaccine rollouts without clinical trials, Europe pins hopes on vaccine campaigns--pandemic related news across the globe
Even as India readies for the mass immunisation drive, there has been a steady decline in the daily number of cases and deaths, since the peak of mid-September. Less than 300 daily coronavirus deaths were recorded in the country for the last 16 days with the national recovery rate improving to 96.42 per cent, according to data from the union health ministry. Given that we will never know the true numbers during the pandemic or even after it, the trajectory is important and it has been on the downward slope, which leads to some pressing questions - Is the worst of the pandemic over? Are the n...
Count 2020 as a lucky year. This may sound odd given that the world grappled with a pandemic that has killed close to 1.8 million people and crippled many countries’ economies. The “luck” relates to the more than 90% efficacy of the two vaccines--Pfizer Inc.-BioNTech SE’s shot and Moderna Inc.’s candidate--that gained emergency approval after thorough clinical analysis. Enormous leaps in science and technology helped make this happen and could well speed the end of the pandemic. And more vaccines are on the way. Unfortunately, there is a risk that this early success leads to compla...